Viewing Study NCT04656106


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2025-12-26 @ 2:40 PM
Study NCT ID: NCT04656106
Status: COMPLETED
Last Update Posted: 2021-09-28
First Post: 2020-11-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module